Back to today’s briefing

Story perspectives

Insurer Maintains Pricing Despite Weight-Loss Drug Lifespan Boost

3/16/2025

33 3

Summary

Story summary

Legal & General, a leading UK insurer, has evaluated the effects of emerging weight-loss medications on life expectancy. Despite the potential for longer lifespans, the company has chosen to maintain current policy pricing and reserves, assuring customers aged 70 and above that their pension payments remain unaffected.

1 of 1

Story summary

Legal & General, a leading UK insurer, has evaluated the effects of emerging weight-loss medications on life expectancy. Despite the potential for longer lifespans, the company has chosen to maintain current policy pricing and reserves, assuring customers aged 70 and above that their pension payments remain unaffected.